摘要
目的探究盐酸氨溴索注射液治疗慢性阻塞性肺疾病(COPD)的临床应用价值。方法选取我院从2016年8月至2017年6月收治的100例COPD患者作为此次试验研究的对象,随机将其分为试验组和参照组,每组各50例患者,参照组患者采取常规药物治疗,试验组患者在此基础上采用盐酸氨溴索注射液治疗,治疗时间为3周。比较两组的临床疗效、不良反应发生率、重度咳嗽率及重度肺部啰音率。结果试验组治疗总有效率明显高于参照组,不良反应发生率、重度咳嗽率及重度肺部啰音率明显低于参照组,组间差异具有统计学意义(P<0.05)。结论与传统常规药物治疗相比,采用盐酸氨溴索注射液治疗COPD效果显著,安全性较高,不良反应现象的发生明显减少,有一定的临床应用价值。
Objective To explore the clinical application value of ambroxol hydrochloride injection in the treatment of chronic obstructive pulmonary disease(COPD).Methods One hundred COPD patients admitted to our hospital from August 2016 to June 2017 were selected as the subjects of this experimental study.They were randomly divided into experimental group and reference group,with 50 patients in each group.Patients in the reference group were taken conventional drug therapy,patients in the experimental group were treated with ambroxol hydrochloride injection on this basis.The treatment time was 3 weeks.The clinical efficacy,the incidence of adverse reactions,the rate of severe cough and the rate of severe pulmonary rales were compared between the two groups.Results The total effective rate of treatment in the experimental group was significantly higher than that of the reference group,and the incidence of adverse reactions,severe coughing and severe rales were significantly lower than the reference group,and the difference between the groups was statistically significant(P<0.05).Conclusion Compared with traditional conventional drug treatment,the use of ambroxol hydrochloride injection to treat COPD has a significant effect,higher safety,and a significant reduction in adverse reactions,which has certain clinical application value.
作者
邓婕
DENG Jie(Department of Respiratory Medicine,Yingkou Xinxing Hospital Co.,Ltd,Yingkou 115001,China)
出处
《中国医药指南》
2020年第29期99-100,共2页
Guide of China Medicine
关键词
慢性阻塞性肺疾病
盐酸氨溴索注射液
临床价值
Chronic obstructive pulmonary diseases
Ambroxol hydrochloride injection
Clinical value